Biochanin A prevents neurodegeneration and oxidative stress in a kainic acid model of epilepsy by activating the PI3K/Akt/Nrf2 signaling pathway

Epilepsy is a serious neurodegenerative disorder, which affects approximately 50 million people worldwide. Growing evidence indicates that oxidative stress caused by an excessive production of free radicals is considered one of the etiologies of epilepsy. Several studies have demonstrated that neurotoxicity-induced oxidative stress leads to neuronal cell death and seizure severity. In this study, we investigated the possible effects of biochanin A (BA), a natural isoflavone containing antioxidant and neuroprotective activities, in a mouse model of epilepsy, induced by an intraperitoneal injection of kainic acid (KA). The administration of KA produced severe seizure activity, and a decrease in memory function. Histological studies following KA injection revealed significant neurodegeneration, astrocyte dysfunction, and microglia activation in CA1, CA3, and hilus of the hippocampus. Moreover, KA administration exhibited an increase in caspase-3, a decrease in antioxidative enzyme levels, and downregulation of the PI3K/Akt/Nrf2 signaling pathway. Conversely, BA treatment significantly increased seizure threshold and memory function. In addition, BA treatment reduced neuronal death, restored astrocyte function, and suppressed microglia activation in CA1, CA3, and hilus. The BA-mediated neuroprotection was accompanied by the significant upregulation of a crucial cellular pathway particularly related to the antioxidant defense system and cell survival, the PI3K/Akt/Nrf2 signaling pathway, thereby increasing antioxidant enzyme levels (GSH, SOD, CAT) and reducing neuronal death. Taken together, our results suggest that BA possesses a neuroprotective effect through bolstering antioxidant defense mechanisms and activating neuronal survival. Thus, BA could be a possible pharmacological agent for the amelioration of epilepsy or other neurodegenerative diseases where oxidative stress is a key factor.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2025-11-13
DOI
https://doi.org/10.1038/s41598-025-23414-z
Primary Topic
Neuroscience and Neuropharmacology Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Biochanin A prevents neurodegeneration and oxidative stress in a kainic acid model of epilepsy by activating the PI3K/Akt/Nrf2 signaling pathway

Napatr Sriraksa, Sataporn Jamsuwan, Lars Klimaschewski, Jinatta Jittiwat et al.
Scientific Reports
Neuroscience and Neuropharmacology Research
article

Biochanin A prevents neurodegeneration and oxidative stress in a kainic acid model of epilepsy by activating the PI3K/Akt/Nrf2 signaling pathway

Napatr Sriraksa, Sataporn Jamsuwan, Lars Klimaschewski, Jinatta Jittiwat, Teera Chanmanee, Tichanon Promsrisuk, Ratchaniporn Kongsui, Sitthisak Thongrong
article en

Abstract

Epilepsy is a serious neurodegenerative disorder, which affects approximately 50 million people worldwide. Growing evidence indicates that oxidative stress caused by an excessive production of free radicals is considered one of the etiologies of epilepsy. Several studies have demonstrated that neurotoxicity-induced oxidative stress leads to neuronal cell death and seizure severity. In this study, we investigated the possible effects of biochanin A (BA), a natural isoflavone containing antioxidant and neuroprotective activities, in a mouse model of epilepsy, induced by an intraperitoneal injection of kainic acid (KA). The administration of KA produced severe seizure activity, and a decrease in memory function. Histological studies following KA injection revealed significant neurodegeneration, astrocyte dysfunction, and microglia activation in CA1, CA3, and hilus of the hippocampus. Moreover, KA administration exhibited an increase in caspase-3, a decrease in antioxidative enzyme levels, and downregulation of the PI3K/Akt/Nrf2 signaling pathway. Conversely, BA treatment significantly increased seizure threshold and memory function. In addition, BA treatment reduced neuronal death, restored astrocyte function, and suppressed microglia activation in CA1, CA3, and hilus. The BA-mediated neuroprotection was accompanied by the significant upregulation of a crucial cellular pathway particularly related to the antioxidant defense system and cell survival, the PI3K/Akt/Nrf2 signaling pathway, thereby increasing antioxidant enzyme levels (GSH, SOD, CAT) and reducing neuronal death. Taken together, our results suggest that BA possesses a neuroprotective effect through bolstering antioxidant defense mechanisms and activating neuronal survival. Thus, BA could be a possible pharmacological agent for the amelioration of epilepsy or other neurodegenerative diseases where oxidative stress is a key factor.

Scientific ReportsVol. 15(1)
Mahasarakham University (TH), Innsbruck Medical University (AT), University of Phayao (TH), Rajabhat Maha Sarakham University (TH)
University of Phayao, Thailand Science Research and Innovation
Openalex Percentile: Top 63%
Neuroscience and Neuropharmacology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.